Solasto Cancels Year-End Dividend as Board Backs Privatization Tender Offer

Solasto Corp. ( (JP:6197) ) has issued an update.

Solasto Corporation has revised its dividend forecast for the fiscal year ending March 31, 2026, deciding that it will pay no year-end dividend, subject to the successful completion of a tender offer by MP-2605 Kabushiki Kaisha to take the company private and delist its shares. The board, which has expressed support for the offer and recommended shareholders tender their shares, said the tender offer price was set on the assumption of no year-end dividend, marking a shift from its usual policy of linking shareholder returns to business performance and signaling a transition toward a non-listed ownership structure.

The company previously projected an annual dividend of 22 yen per share for the year, including an 11 yen year-end payment, but now plans a total of 11 yen, all of which has already been paid as an interim dividend. This move aligns Solasto’s capital policy with the terms of the buyout transaction and affects current shareholders by concentrating their return into the tender offer price rather than ongoing cash dividends, while also underscoring the strategic importance the board places on the privatization deal and its expected impact on future governance and financial flexibility.

The most recent analyst rating on (JP:6197) stock is a Hold with a Yen1094.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

More about Solasto Corp.

Solasto Corporation is a Japan-based company listed on the Tokyo Stock Exchange Prime Market under code 6197. The company operates in the healthcare and nursing care services sector, with a focus on medical administration outsourcing and related support services for hospitals and care facilities across Japan.

Average Trading Volume: 1,304,501

Technical Sentiment Signal: Buy

Current Market Cap: Yen104.6B

Learn more about 6197 stock on TipRanks’ Stock Analysis page.